Tirzepatide and Semaglutide are injectable medications that mirror the natural hormone glucagon-like peptide-1 (GLP-1) to not only manage blood sugar but also aid weight loss, promote heart health, preserve beta-cell function, and lower the risk of hypoglycemia.
How Do GLP-1 Medications Help For Weight Loss?
GLP-1 (glucagon-like peptide-1) agonist mimics the human hormone in several ways to help control blood sugar and reduce hunger:
- Stimulates insulin production. GLP-1 agonists stimulate the pancreas to release insulin when blood sugar levels rise after eating which then increases blood sugar disposal.
- Inhibits glucagon. GLP-1 agonists suppress the release of glucagon which is another hormone that affect blood sugar levels.
- Slows gastric emptying. GLP-1 agonists delay how quickly the stomach empties after eating which helps you feel full for longer.
- Reduce food intake. GLP-1 agonists suppress appetite and signal fullness. It helps to reduce “food noise” or repetitive and obsessive thoughts around food which often lead to unhealthy eating habits.
What is Semaglutide?
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist initially prescribed for type 2 diabetics, now stands as a groundbreaking treatment addressing both diabetes and obesity. Administered weekly via injections, it not only effectively regulates blood sugar levels but also induces significant weight loss. This multifaceted approach offers a comprehensive solution for individuals grappling with the challenges of type 2 diabetes and obesity, making semaglutide a remarkable and versatile therapeutic option at the intersection of metabolic health and weight management.
What is Tirzepatide?
Tirzepatide, a cutting-edge dual GIP (glucose-dependent insulinotropic peptide) and GLP-1 (glucacon-like peptide-1) receptor agonist, signifies a transformative breakthrough in type 2 diabetes and obesity treatment. Administered weekly through injections, it not only effectively manages blood sugar levels but also stands out for its remarkable weight loss benefits. As the next-generation GLP-1, tirzepatide represents an innovative approach at the forefront of metabolic health solutions. Its dual-action mechanism and proven efficacy make it a versatile therapeutic option, demonstrating unprecedented promise for individuals seeking simultaneous management of type 2 diabetes and obesity, offering comprehensive care and improved overall metabolic well-being.
Semaglutide
$350 per vial
Tirzepatide
$500 per vial
Semaglutide
$500
$500 for the first 3 months (paid in full at first visit), then $500 every 5 weeks thereafter for refills
Tirzepatide
$750
$750 for the first 7 weeks (paid in full at first visit), then $750 every 4-5 weeks thereafter for refills
What would disqualify me from taking Semaglutide and Tirzepatide?
To ensure your safety, patients who have any of the following medical conditions will NOT be eligible for medical weight loss with Poppy Aesthetics:- BMI less than 25
- Type 1 Diabetic
- Low blood sugar
- Diabetic retinopathy
- Eating disorder
- Decreased kidney function or kidney disease
- Acute inflammation of the pancreas or pancreatitis
- Medullary thyroid cancer
- Multiple endocrine neoplasia type 2
- Family history of medullary thyroid carcinoma
- HIV/AIDS
- Those undergoing or have undergone chemo/radiation in the last 12 months
- Pregnant or those attempting to conceive in the next 3 months for both men and women
Are there side effects?
Side effects vary from person to person. The most commonly reported effects may include:- Diarrhea
- Constipation
- Nausea and/or vomiting
- Abdominal pain
- Lack of appetite
- Heartburn
- Irritation at injection sites